8-86626069-A-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM1BP4_StrongBP6BS1BS2_Supporting

The NM_019098.5(CNGB3):​c.1492T>A​(p.Leu498Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000578 in 1,611,844 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0032 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00030 ( 3 hom. )

Consequence

CNGB3
NM_019098.5 missense

Scores

6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 2.09
Variant links:
Genes affected
CNGB3 (HGNC:2153): (cyclic nucleotide gated channel subunit beta 3) This gene encodes the beta subunit of a cyclic nucleotide-gated ion channel. The encoded beta subunit appears to play a role in modulation of channel function in cone photoreceptors. This heterotetrameric channel is necessary for sensory transduction, and mutations in this gene have been associated with achromatopsia 3, progressive cone dystrophy, and juvenile macular degeneration, also known as Stargardt Disease. [provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PM1
In a topological_domain Extracellular (size 65) in uniprot entity CNGB3_HUMAN there are 9 pathogenic changes around while only 1 benign (90%) in NM_019098.5
BP4
Computational evidence support a benign effect (MetaRNN=0.015865922).
BP6
Variant 8-86626069-A-T is Benign according to our data. Variant chr8-86626069-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 421450.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00323 (492/152312) while in subpopulation AFR AF= 0.0111 (460/41572). AF 95% confidence interval is 0.0102. There are 1 homozygotes in gnomad4. There are 242 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNGB3NM_019098.5 linkc.1492T>A p.Leu498Met missense_variant Exon 13 of 18 ENST00000320005.6 NP_061971.3 Q9NQW8-1
CNGB3XM_011517138.3 linkc.1078T>A p.Leu360Met missense_variant Exon 11 of 16 XP_011515440.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNGB3ENST00000320005.6 linkc.1492T>A p.Leu498Met missense_variant Exon 13 of 18 1 NM_019098.5 ENSP00000316605.5 Q9NQW8-1
CNGB3ENST00000681546.1 linkn.1312T>A non_coding_transcript_exon_variant Exon 8 of 13
CNGB3ENST00000681746.1 linkn.1492T>A non_coding_transcript_exon_variant Exon 13 of 19 ENSP00000505959.1 A0A5J6DSN8

Frequencies

GnomAD3 genomes
AF:
0.00323
AC:
491
AN:
152194
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00138
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00430
GnomAD3 exomes
AF:
0.000862
AC:
216
AN:
250664
Hom.:
1
AF XY:
0.000642
AC XY:
87
AN XY:
135462
show subpopulations
Gnomad AFR exome
AF:
0.0106
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000441
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000301
AC:
439
AN:
1459532
Hom.:
3
Cov.:
30
AF XY:
0.000253
AC XY:
184
AN XY:
726230
show subpopulations
Gnomad4 AFR exome
AF:
0.00997
Gnomad4 AMR exome
AF:
0.00116
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000811
Gnomad4 OTH exome
AF:
0.000730
GnomAD4 genome
AF:
0.00323
AC:
492
AN:
152312
Hom.:
1
Cov.:
32
AF XY:
0.00325
AC XY:
242
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.0111
Gnomad4 AMR
AF:
0.00137
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00426
Alfa
AF:
0.000473
Hom.:
0
Bravo
AF:
0.00366
ESP6500AA
AF:
0.0118
AC:
52
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00104
AC:
126
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 10, 2016
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The L498M variant in the CNGB3 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The NHLBI ESP Exome Sequencing Project reports L498M was observed in 52/4406 (1.2%) alleles from individuals of African American background, with one homozygous individual reported, indicating it may be a rare benign variant in this population. The L498M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Leucine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret L498M as a variant of uncertain significance. -

Achromatopsia 3;C1855465:Severe early-childhood-onset retinal dystrophy Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Achromatopsia Benign:1
Nov 11, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

CNGB3-related disorder Benign:1
Oct 25, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T
Eigen
Benign
0.087
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.016
T
MetaSVM
Uncertain
0.77
D
MutationAssessor
Uncertain
2.8
M
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.9
N
REVEL
Uncertain
0.46
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.010
D
Polyphen
1.0
D
Vest4
0.53
MVP
0.91
MPC
0.21
ClinPred
0.074
T
GERP RS
0.29
Varity_R
0.17
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115246141; hg19: chr8-87638297; API